As a PhD student, I conduct research in precision medicine, focusing on pharmacogenomics, epigenomics and pharmacoepidemiology. My work aims to improve the identification of individuals at high risk of serious cardiac side effects from medications. I am a medical doctor with clinical, research and teaching experience.

I conduct research on pharmacogenomics in psychiatry, focusing on genetic and epigenetic markers linked to drug-induced QT prolongation. Using registry and biobank data, I aim to improve early identification of patients at risk of serious cardiac side effects. This may support safer prescribing of psychotropic drugs and help personalise treatment decisions.

My primary area of responsibility is the design and conduct of research projects in precision medicine, including pharmacogenomics and drug utilisation. I also work with project planning, interdisciplinary and international collaboration, and scientific communication.